Sign In
Buy CLXPF
$0.82
+0 (+0%)
At Close: Aug 17, 2022
Penny Stocks To Buy Today? 3 To Watch Before Thanksgiving
03:01pm, Tuesday, 21'st Nov 2023
Is the stock market open on Thanksgiving? No, but that doesn't mean the shortened holiday week won't be packed with stock market moving catalysts.
Buying Cybin Stock Right Now Could Be a Brilliant Move
06:19am, Thursday, 02'nd Sep 2021
You'll need to be prepared for a long holding period and a hearty helping of risk.
Cybin Announces Additional Adelia Milestone Achievements
05:51pm, Tuesday, 31'st Aug 2021
TORONTO--(BUSINESS WIRE)--Cybin Announces Additional Adelia Milestone Achievements
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
12:32pm, Thursday, 19'th Aug 2021
Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional international patent applications; these applications open the possibi
TORONTO--(BUSINESS WIRE)--Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders' Meeting and Adoption of Shareholder Rights Plan
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
02:51pm, Thursday, 05'th Aug 2021
Cybin (NYSE:CYBN), a biotech company in the psychedelics space, began listing its stock on the New York Stock Exchange on Thursday. The company is the first in the sector to enter the NYSE, following
Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE
02:03pm, Thursday, 22'nd Jul 2021
Cybin Inc. (NEO: CYBN) (OTCQB:CLXPF), a biotech company in the psychedelics space, announced on Thursday a conditional approval to list on the New York Stock Exchange. “A tier 1 listing in the U.S.
Cybin Announces Conditional Listing Approval from NYSE American
08:37pm, Wednesday, 21'st Jul 2021
TORONTO--(BUSINESS WIRE)--Cybin Announces Conditional Listing Approval from NYSE American
Missed the Initial Cannabis Boom? Check Out Hot Psychedelic Stock Cybin
05:55am, Thursday, 01'st Jul 2021
The psychedelic-drug market is still in its early stages. And Cybin stands out as an early leader.
Cybin Inc Biotech Co Reports $51 Million In Cash As Stifel Ups Price Target To $12
10:41pm, Monday, 28'th Jun 2021
Psychedelics companies continue to receive welcoming signs from Wall Street. As more companies commence their Nasdaq listings, investment banks are also jumping in with open arms.
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
08:06am, Monday, 28'th Jun 2021
TORONTO--(BUSINESS WIRE)--Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
Cybin Inc. Releases Annual Financials and Provides Business Highlights
08:03am, Monday, 28'th Jun 2021
TORONTO--(BUSINESS WIRE)--Cybin Inc. Releases Annual Financials and Provides Business Highlights
3 Reasons to Buy Cybin Stock, and 1 Reason to Sell
06:10am, Saturday, 26'th Jun 2021
Several critical pieces are starting to fall into place for this clinical-stage biotech.
Cybin to Participate in Grizzle Psychedelics Con on June 28th
07:00am, Friday, 25'th Jun 2021
TORONTO--(BUSINESS WIRE)--Cybin to Participate in Grizzle Psychedelics Con on June 28th
